Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Isopropyl 3-(3,4-Dihydroxyphenyl)-2-Hydroxypropanoate Attenuates Experimental Renal Ischemia-Reperfusion Injury by Limiting Sterile Inflammation and Preserving Mitochondrial Function: Involvement of an Nrf2-Associated Cytoprotective Response.

Journal of inflammation research·2026
Same author

Synergistic regulation of iron cycle and hydroxyl radical generation in sodium percarbonate-based Fenton reaction enables efficient degradation of chlorinated hydrocarbons.

Journal of hazardous materials·2026
Same author

A Quantum Self-Attention Neural Network Model on Quantum Circuits.

IEEE transactions on cybernetics·2026
Same author

Construction of phosphorus and cobalt co-modified tubular carbon nitride with dual reaction sites for boosted imidacloprid degradation.

Journal of colloid and interface science·2026
Same author

Latent profile analysis of digital health literacy among community-dwelling older adults and its influencing factors.

Digital health·2026
Same author

Four-dimensional left ventricular motion clustering reveals cardiovascular phenotypes at population scale.

Scientific reports·2026

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Manuela Polydoro1, Ivana Geric2, Jin Zheng1

  • 1Muna Therapeutics, Copenhagen, Capital Region, Denmark.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括

MTX46943是一种新型TREM2激动剂,通过稳定TREM2/DAP12复合体,激活微质并减少阿尔茨海默病的病理学. 这种小分子疗法显示出早期AD治疗的潜力.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 微质细胞是大脑中关键的先天性免疫细胞,对于维持健康和解决阿尔茨海默病 (AD) 病理学至关重要.
  • TREM2 (Triggering Receptor Expressed on Myeloid cells 2) 是一种可调节微质对错误折叠蛋白质的反应的受体,对神经元功能至关重要.
  • MTX46943是一种新的,强效的,选择性的,安全的,并透大脑的小分子激动剂,向TREM2用于早期AD治疗.

研究的目的:

  • 研究TREM2激动剂MTX46943在激活微质和减少AD病理方面的作用机制和疗效.
  • 描述MTX46943对TREM2受体复合体动态和微质功能的下游影响.
  • 评估慢性MTX46943治疗在AD小鼠模型中对粉样蛋白病理的体内影响.

主要方法:

  • 实验室试验 (纳米BiT,西斑,alphaLISA,迁移,细胞) 用于评估TREM2激活和各种细胞类型的下游影响.
  • 将MTX46943与TREM2主动体抗体进行比较,以区分受体激活方式.
  • 在体内研究涉及5xFAD // hTREM2敲入小鼠的慢性治疗,随后使用qPCR分析微质和脑组织,单细胞RNA测序和免疫染.

主要成果:

  • MTX46943促进TREM2/DAP12受体复合体的形成,并稳定其表面存在,对于微质激活至关重要,与抗体激动剂不同.
  • 在体内,MTX46943治疗在粉样蛋白病理存在时重新编程了微质,导致神经毒性粉样蛋白β物种的显著减少.
  • 在体内观察到的效果与MTX46943在脑透暴露水平的体外效果一致.

结论:

  • MTX46943是一种选择性TREM2激动剂,正在为早期阿尔茨海默病治疗进行临床研究.
  • 该研究表明MTX46943的差异化机制涉及TREM2受体复合体稳定和微质重编程.
  • 慢性MTX46943治疗显著降低了大脑粉样蛋白病理,并支持其作为AD类最佳治疗方法的潜力.